Skip to main content
logo
Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.1710
-0.0241 (-12.34%)
At close: Jan 9, 2026

Lipella Pharmaceuticals Revenue

Lipella Pharmaceuticals had revenue of $389.78K in the twelve months ending September 30, 2025, down -19.39% year-over-year. In the year 2024, Lipella Pharmaceuticals had annual revenue of $536.36K with 19.29% growth.

Revenue (ttm)
389.78K
Revenue Growth
-19.39%
P/S Ratio
2.03
Revenue / Employee
64.96K
Employees
7
Market Cap
790.16K

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024536.36K86.74K19.29%
Dec 31, 2023449.62K265.46K144.15%
Dec 31, 2022184.16K-75.19K-28.99%
Dec 31, 2021259.35K-702.34K-73.03%
Dec 31, 2020961.68K266.94K38.42%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Glass House Brands196.17M
Vaxart148.20M
Elite Pharmaceuticals122.89M
Zomedica29.45M
Silence Therapeutics25.83M
OpGen9.00M
Revenue Rankings

Lipella Pharmaceuticals News

More News